- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01664780
Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation
Aims: Prospective evaluation of the applicability of acoustic radiation force impulse(ARFI) imaging to assess liver fibrosis in patients after orthotopic liver transplantation.
Material and methods: We prospectively assess the performance of ARFI imaging in planned 100 patients after orthotopic liver transplantation. We evaluate shear wave velocity of the left and right liver lobe with the convex array (6C1HD)ultrasound transducer and compare the results with clinical data and B-mode criteria.
ARFI elastometry is an increasingly popular non-invasive method for the assessment of hepatic fibrosis and cirrhosis. To date, ARFI technology has not been applied systematically in patients after orthotopic liver transplantation. Therefore we want to establish standard values in this population.
Study Overview
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Erlangen, Germany, 91054
- Recruiting
- University Hospital of Erlangen, Dep. of Medicine 1
-
Contact:
- Dane Wildner, MD
- Phone Number: 0049 9131 8535250
- Email: dane.wildner@uk-erlangen.de
-
Contact:
- Steffen Zopf, MD
- Phone Number: 0049 9131 8535250
- Email: steffen.Zopf@uk-erlangen.de
-
Sub-Investigator:
- Deike Strobel, MD
-
Principal Investigator:
- Dane Wildner, MD
-
Principal Investigator:
- Steffen Zopf, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients after orthotopic liver transplantation.
Exclusion Criteria:
- Patients without status after orthotopic liver transplantation.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients after liver transplantation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dane Wildner, MD, Dep. of Medicine 1, University of Erlangen-Nuremberg
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ARFI-UK Erlangen
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplantation
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
The Hospital for Sick ChildrenCompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCanada
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.Active, not recruitingLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Czechia, France, Germany, Italy, Poland, United Kingdom
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLiver Transplantation | Kidney TransplantationFrance
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Rennes University HospitalCompletedLiver Transplantation | Kidney TransplantationFrance
Clinical Trials on ARFI imaging
-
University of MichiganWithdrawnKidney Damage | Urine RefluxUnited States
-
Yonsei UniversitySeverance HospitalUnknownHIV InfectionKorea, Republic of
-
Yonsei UniversitySeverance HospitalCompletedChronic Liver DiseaseKorea, Republic of
-
Children's Hospital Medical Center, CincinnatiSiemens Medical SolutionsCompleted
-
Johann Wolfgang Goethe University HospitalCompletedChronic Hepatitis CNetherlands, Germany, France
-
Heidelberg UniversitySiemens Medical SolutionsCompletedBreast NeoplasmsGermany, United States, France, Japan, Netherlands, Portugal
-
University Hospital, BordeauxCompleted
-
University of Erlangen-Nürnberg Medical SchoolAdrian RegensburgerRecruitingCystic Fibrosis | Liver Fibrosis | Gastrointestinal Transport Disorder | DiosGermany
-
University of MichiganChildren's Hospital Medical Center, CincinnatiCompletedLiver FibrosesUnited States
-
University of MichiganCompleted